Four in ten EEA doctors considering quitting, says survey.
Company looking to smartwatch and health markets as next step.
Activist investor’s intervention adds to buzz surrounding BMS.
10/03/2017February 8, 2017
02/11/2016November 1, 2016
22/11/2016October 20, 2016
‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.